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Abstract: Several benzo[b]thienyldehydrophenylalanines were synthesized from pure 
stereoisomers of the methyl ester of N-(tert-butoxycarbonyl)-β-
bromodehydrophenylalanine as an extension of our previously reported method for the 
synthesis of dehydrotryptophan analogues to dehydrophenylalanine derivatives. The 
latter were obtained in high yields by N-deprotection and bromination of N,N-bis-(tert-
butoxycarbonyl)-(Z)-dehydrophenylalanine using TFA and NBS.  This was carried out 
in two steps or in a one pot procedure resulting in different E/Z ratios. These compounds 
were coupled under Suzuki cross-coupling conditions [Pd(PPh3)4, Na2CO3, DME/H2O] 
with several boronic benzo[b]thienyl acids in good to high yields maintaining the 
stereochemistry of the starting materials. The best yields were obtained when the 
boronic acid was in position 7 of the benzo[b]thiophene and with the E isomer of the 
brominated dehydrophenylalanine. In some cases it was possible to increase the lower 
yields by changing the Pd source to PdCl2(PPh)2. A model dipeptide was prepared 
coupling a benzo[b]thienyldehydrophenylalanine with the methyl ester of alanine. 
Preliminary antimicrobial studies were performed with both isomers of one of the β, β-
diaryldehydroalanines obtained. The results show that the compounds are selective and 
very active (very low MICs) against Gram positive bacteria (B. cereus and B. subtilis) 
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the Z-isomer being more active. The compounds are also active against Candida 
albicans presenting similar MICs.  
______________________________________________________________________ 
 
 
1. Introduction 
 
Dehydroamino acids have been found in several natural peptides from microbial or 
marine sources. The incorporation of α,β-dehydroamino acids constitutes a valuable tool 
in structure-activity relationship (SAR) studies, due to the conformational constraints 
they impose. These restrained analogues of  amino acids mainly dehydrophenylalanine 
and dehydrotyrosine have been introduced in peptide sequences to probe the preferred 
orientations of these residues once bound to the receptors.1 These molecules can also be 
very useful as pharmaceutical probes towards various proteases, namely HIV-proteases.2 
The dehydrophenylalanine residue as a constrained phenylalanine mimic has gained 
much importance, in particular, because of its turn inducing as well as helix-forming 
propensity.3 Studies have indicated that the α,β-double bond of dehydroamino acids 
does not in itself cause reversal in the peptide backbone and the preferred conformation 
of a dehydropeptide may be decided by the nature of the β-substituents. Thus, different 
dehydroamino acids can be used to introduce different kinds of constraints in peptides.4 
Recently, we have been interested in the synthesis of new β-substituted dehydroamino 
acids either by Michael additions5 or by palladium catalyzed cross-couplings.6a-c The 
fluorescence studies performed on β-benzo[b]thienyldehydroamino acids already 
prepared by us showed that some of them can also be used as fluorescent probes.6c  
Here we describe the synthesis of benzo[b]thienyldehydrophenylalanines using Suzuki 
cross-coupling7 of several boronic benzo[b]thienyl acids with pure stereoisomers of a β-
bromodehydrophenylalanine derivative. Two of the β, β-diaryldehydroalanines obtained 
were tested for antimicrobial activity and showed to be active with low minimal 
inhibitory concentration (MIC). The insertion of this type of compounds in peptides was 
demonstrated preparing a model dipeptide using DCC/HOBt.  
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2. Results and discussion 
 
The methyl ester of N,N-bis-(tert-butoxycarbonyl)-(Z)-dehydrophenylalanine5 (Boc2-
∆Phe-OMe) was N-monodeprotected5 with TFA and β-brominated with NBS followed 
by treatment with NEt3 to give the methyl ester of N-(tert-butoxycarbonyl)-β-
bromodehydrophenylalanine [Boc-∆Phe(β-Br)-OMe)] as a 1:2 E/Z mixture in an overall 
yield of 89%. The same reactions performed in a one pot procedure gave the products in 
a similar yield but resulted in a higher selectivity towards the Z isomer (1:6 E/Z) 
(Scheme 1). These results are similar to those obtained by us in the bromination of 
dehydroaminobutyric acid.6a 
 
 
Scheme 1. Synthesis of compounds (E)-1 and (Z)-1 in two steps or in a one pot procedure.
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The stereochemistry of (E) and (Z)-1 was determined by NOE difference experiments 
irradiating the α-NH and observing a NOE effect on the signal of the phenyl protons of 
(E)-1 (Fig. 1) while for compound  (Z)-1 this was not observed (Fig. 2). 
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(E)-1
 
 
Figure 1 – 1H-NMR spectrum (CDCl3) of (E)-1 and NOE difference experiment 
irradiating the α-NH and observing the effect on the signal of the phenyl protons. 
 
(Z)-1
 
 
Figure 2 – 1H-NMR spectrum (CDCl3) of (Z)-1 and NOE difference experiment 
irradiating the α-NH. 
 
The pure stereoisomers (E) and (Z)-1 were coupled with several boronic benzo[b]thienyl 
acids under Suzuki cross-coupling conditions6a to give β- 
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benzo[b]thienyldehydrophenylalanines in good to high yields (Scheme 2). NOE 
difference experiments irradiating the α-NH confirmed that the coupled products 
maintained the stereochemistry of the starting materials.  
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Scheme 2. Synthesis of compounds (E)-2a-c and (Z)-2a-c under Suzuki cross-coupling conditions.
i) Pd(PPh3)4 (10 mol%), Na2CO3 (2 eq.), boronic acid (1.3 eq.), DME/H2O (4:1), 90 
oC, 3-5 h.
ii) same conditions but using PdCl2(PPh3)2 (10 mol%).
H
N CO2Me
Br
Boc
H
N CO2MeBoc
Br
(E)-1
  (Z)-1
S
B(OH)2
S
B(OH)2
S
i
i
i
H
N CO2MeBoc
S
H
N CO2MeBoc
S
H
N CO2MeBoc
(E)-2a, 70%
(E)-2b, 60%
(E)-2c, 96%
H
N CO2MeBoc
S
(Z)-2a, 61% (i), 
           74% (ii)
S
B(OH)2
i or ii
i or ii
B(OH)2
S
B(OH)2
S
B(OH)2
i or ii
H
N CO2MeBoc
S
H
N CO2MeBoc
S
(Z)-2b, 50% (i), 
           66% (ii)
(Z)-2c, 74% (i), 
           73% (ii)
S
 
 7
 
The best yields were obtained when the boronic acid was in position 7 of the 
benzo[b]thiophene moiety. In all cases using the same catalytic conditions (i), the higher 
yields were obtained from compound (E)-1 which can be due to the lower steric 
hindrance of this derivative. 
In order to increase the yields of the Z isomers, another palladium catalyst 
[PdCl2(PPh3)2], that had already given good results in the synthesis of  β,β-bis-
(benzo[b]thienyl)dehydroalanines from a β,β-dibromodehydroalanine derivative, was 
used.6c In these conditions (ii), when the boronic acids are in the thiophene ring the 
yields increased from 61% to 74% in the synthesis of (Z)-2a and from 50% to 66% in 
the synthesis of (Z)-2b. This increase was not observed in the synthesis of compound 
(Z)-2c which was obtained in similar yields using both catalytic systems (Scheme 2). 
A dipeptide was prepared from (E)-2b by C-deprotection and coupling with the methyl 
ester of alanine  using DCC/HOBt (Scheme 3). 
 
Scheme 3. Synthesis of dipeptide 4 from (E)-2b and the methylester of alanine.
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This result in the synthesis of a model dipeptide shows that our β, β-
diaryldehydroamino acids can be inserted into peptides. 
A screening of antibacterial activities using two Gram negative (Escherichia coli and 
Pseudomonas aeruginosa) and two Gram positive bacteria (Bacillus subtilis and Bacillus 
cereus) and antifungal activity using Candida albicans  as a representative of fungi was 
assessed for compounds (Z)-2c and  (E)-2c. The MIC (in µg/mL) was determined (Table 
1) using an adaptation of agar streak dilution method based on radial diffusion.[8] In the 
same conditions different concentrated solutions of Ampiciline (antibacterial) and 
Cyclohexamide (antifungal) were used as standards. The MIC was considered to be the 
lowest concentration of the tested compound which inhibits growth of bacteria or fungi 
on the plate. The compounds tested were inactive against the Gram- bacteria 
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(Escherichia coli and Pseudomonas aeruginosa). The diameters of the inhibition zones 
corresponding to the MICs for the Gram+ bacteria  and for C. albicans are presented in 
Table 1.  
 
Table 1. Antimicrobial activity of compounds (Z)-2c and  (E)-2c. 
 
Compounds 
 
MIC in µg/mL    (Zone of inhibition in mm ) 
 Bacillus cereus 
CECT148 
Bacillus subtilis  
CECT498 
Candida albicans 
CECT 1394 
(E)-2c 0.125 (13) 0.125 (15) 0.125 (6) 
(Z)-2c 1.25x10-3 (15) 1.25x10-3 (11) 0.125 (5) 
Ampiciline 3.13 (13) 12.5 (10) ______ 
Cyclohexamide ______ ______ 12.5 (5) 
CECT-Spanish type culture collection of Valencia University 
 
From the inspection of Table 1 it is possible to conclude that the compounds tested are 
active against B.cereus, B.subtilis and C. albicans presenting MICs very much lower 
than those obtained with Ampiciline (antibacterial) and Cyclohexamide (antifungal).  
Compound (Z)-2c shows lower MICs than (E)-2c for Gram + bacteria but the results 
against C. albicans are similar for both isomers. These results indicate that the 
compounds are selective and very active (very low MICs) against the Gram + bacteria 
tested and against a representative of fungi, thus showing very interesting antimicrobial 
properties. 
  
3. Conclusion 
 
Several β,β-diaryldehydroamino acids in the benzo[b]thiophene series were synthesized 
in good to high yields from pure stereoisomers of a β-bromodehydrophenylalanine 
derivative and benzo[b]thienylboronic acids using C-C paladium-catalyzed cross-
couplings. From the results obtained we can conclude that the E isomer of the β-
brominated dehydrophenylalanine (E)-1 is more reactive under Suzuki cross coupling 
conditions then the Z isomer. It is also possible to conclude that the 7-
benzo[b]thienylboronic acid is the most reactive, and its reactivity does not depend on 
the Pd source. The insertion of this type of compounds in peptides was tested preparing a 
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model dipeptide in high yield. Preliminary antimicrobial studies were performed using 
both isomers of one of the β, β-diaryldehydroalanines obtained. The results show that 
the compounds are selective and very active (very low MICs) against Gram + bacteria 
(B. cereus and B. subtilis), the Z-isomer being more active. The compounds are also 
active against Candida albicans presenting similar MICs.  
 
 
4. Experimental 
4.1. General 
Melting points (oC) were determined in a Gallenkamp apparatus and are uncorrected. 1H 
and 13C NMR spectra were recorded on a Varian Unity Plus at 300 and 75,4 MHz 
respectively. 1H-1H spin-spin decoupling and DEPT θ 45º were used. Chemical shifts are 
given in ppm and coupling constants in Hz. MS and HRMS data were recorded by the 
mass spectrometry service of the University of Vigo, Spain. Elemental analysis was 
performed on a LECO CHNS 932 elemental analyser. 
The reactions were monitored by thin layer chromatography (TLC). Column 
chromatography was performed on Macherey-Nagel silica gel 230-400 mesh. Petroleum 
ether refers to the boiling range 40-60 oC. When solvent gradient was used, the increase 
of polarity was made from neat petroleum ether to mixtures of ether/petroleum ether, 
increasing 10% of ether each time until the isolation of the product.  
4.2. Synthesis of Boc-(E)-∆Phe(β-Br)-OMe (E-1) and Boc-(Z)-∆Phe(β-Br)-OMe (Z-
1): Boc-∆Phe-OMe5 (1.39 g, 5.00 mmol) was dissolved in dichloromethane (0.1 M) and 
1.2 eq. of N-bromosuccinimide (0.980 g, 5.50 mmol) were added with vigorous stirring. 
After reacting for 16 hours, triethylamine (1.5 eq.) was added and stirring continued for 
an additional hour. Dicloromethane (50 mL) was added and the organic phase was 
washed with water and brine (3x30 mL each). After drying over MgSO4 the extract was 
taken to dryness at reduced pressure to give (E)-1 and (Z)-1 (1.73 g, 97%) as a 1:2 
mixture.   The diastereomers were separated by column chromatography using solvent 
gradient from neat petroleum ether to 20% diethyl ether/petroleum ether to give (Z)-1 
mp 101-103 °C (from diethyl ether/n-hexane). 1H NMR (CDCl3): 1.49 (9H, s, CH3Boc), 
3.53 (3H, s, OCH3), 6.55 (1H, s, αNH), 7.34 (5H, br s, ArH). 13C NMR (CDCl3): 28.06 
(C(CH3)3), 52.43 (OCH3), 82.10 (OC(CH3)3), 128.21 (CH), 128.94 (CH), 129.11 (CH), 
129.31 (C), 137.39 (C), 151.89 (C=O), 163.47 (C=O) ppm. Anal. calcd. for 
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C15H18NO4Br (356.22): C 50.58; H 5.09; N 3.93; found C 50.61; H 5.12; N 4.01.   (E)-1 
mp 80-81 °C (from petroleum ether). 1H NMR (CDCl3): 1.43 (9H, s, CH3Boc), 3.93 
(3H, s, OCH3), 6.08 (1H, s, αNH), 7.43 (5H, br s, ArH). 13C NMR (CDCl3): 28.01 
(C(CH3)3), 52.58 (OCH3), 82.00 (OC(CH3)3), 128.58 (CH), 128.94 (CH), 129.04 (CH), 
129.47 (C), 136.50 (C), 151.56 (C=O), 164.55 (C=O) ppm. Anal. calcd. for 
C15H18NO4Br (356.22): C 50.58; H 5.09; N 3.93; found C 50.74; H 5.21; N 4.09.  
One pot procedure: Boc2-∆Phe-OMe5 (1.86 g, 5.00 mmol) was dissolved in 
dichloromethane (0.1 M) and 2% of TFA slowly added with vigorous stirring. The 
reaction was monitored by TLC and when no starting material was detected (≈1 hour) 
1.2 eq. of N-bromosuccinimide (1.34 g, 7.50 mmol) were added. After reacting for 16 
hours triethylamine (15.0 mmol) was added and stirring continued for an additional 
hour. Dichoromethane was added (50 mL) and the organic phase was then washed with 
water and brine (2x30 mL each ). After drying over MgSO4, the extract was taken to 
dryness at reduce pressure to afford a 1:6 mixture of (E)-1 and (Z)-1 (1.48 g, 83%).  
4.3.General procedure for Suzuki cross couplings: To a solution of compound (E)-1 
or (Z)-1 in DME/water (4/1), benzo[b]thienylboronic acids (1.1 eq.), Na2CO3 (2 eq.) and 
Pd(PPh3)4 (10 mol%) were added and the mixture was heated at 90 ºC while the reaction 
was monitored by TLC. The DME was removed under reduced pressure and the residue 
was dissolved in ethyl acetate (15 mL). The organic layer was then washed with water 
and brine (3x5 mL) dried with MgSO4 and  the solvent evaporated at reduce pressure to 
give an oil which was submitted to column chromatography. 
 
4.3.1. Boc-(E)-∆Phe(β-benzo[b]thien-2-yl)-OMe (E-2a): The procedure described 
above was applied using compound (E)-1 (107 mg, 0.300 mmol) and the 2-
benzo[b]thienylboronic acid (0.330 mmol, 59.0 mg) and heating for 3h 30m. Column 
chromatography using a solvent gradient from pure petroleum ether to 30% diethyl ether 
in petroleum ether, gave compound (E)-2a (86.0 mg, 70%) as an oil. Recrystallization 
from diethyl ether/petroleum ether afforded light yellow crystals, mp 97-99 ºC. 1H NMR 
(CDCl3): 1.46 (9H, s, CH3 Boc), 3.69 (3H, s, OCH3), 6.17 (1H, br s, NH), 7.16 (1H, s, 
ArH), 7.29-7.43 (7H, m, ArH), 7.69-7.74 (2H, m, ArH) ppm. 13C NMR (CDCl3): 28.09 
(C(CH3)3), 52.58 (OCH3), 81.77 (OC(CH3)3), 122.05 (CH), 123.60 (CH), 124.33 (CH), 
124.43 (CH), 124.55 (CH), 127.44 (C), 128.83 (CH), 129.02 (CH), 129.62 (CH), 137.33 
 11
(C), 139.31 (C), 140.72 (C), 141.97 (C), 152.12 (C=O), 166.01 (C=O) ppm. Anal. calcd. 
for C23H23NO4S (409.50): C 67.46; H 5.66; N 3.42; S 7.83; found C 67.25; H 5.93; N 
3.39; S 7.36. 
 
4.3.2. Boc-(Z)-∆Phe(β-benzo[b]thien-2-yl)-OMe (Z-2a): The procedure described 
above was applied using compound (Z)-1 (107 mg, 0.300 mmol) and the 2-
benzo[b]thienylboronic acid (59.0 mg, 0.330 mmol) and heating for 5h. Column 
chromatography using a solvent gradient from pure petroleum ether to 30% diethyl ether 
in petroleum ether, gave compound (Z)-2a (75.0 mg, 61%) as an oil. Recrystallization 
from diethyl ether/petroleum ether afforded colourless crystals, mp 123-124 ºC. 1H 
RMN (CDCl3): 1.52 (9H, s, CH3 Boc), 3.49 (3H, s, OCH3), 6.55 (1H, br s, NH), 7.08 
(1H, s, ArH), 7.28-7.41 (7H, m, ArH), 7.67-7.76 (1H, m, ArH), 7.80-7.83 (1H, m, ArH) 
ppm. 13C RMN (CDCl3): 28.15 (C(CH3)3), 51.96 (OCH3), 81.59 (OC(CH3)3), 122.01 
(CH), 123.57 (C), 124.00 (CH), 124.59 (CH), 125.31 (CH), 125.87 (C), 127.80 (CH), 
128.07 (CH), 128.24 (CH), 129.38 (CH), 138.79 (C), 138.85 (C), 140.77 (C), 152.84 
(C=O), 165.89 (C=O) ppm. Anal. calcd. for C23H23NO4S (409.50): C 67.46; H 5.66; N 
3.42; S 7.83; found C 67.58; H 5.74; N 3.48; S 7.70. The procedure described above 
using 0.5 mmol of (Z)-1 and substituting PdCl2(PPh3)2 for Pd(PPh3)4 was used giving 
compound (Z)-2a (150 mg, 74%). 
 
 4.3.3. Boc-(E)-∆Phe(β-benzo[b]thien-3-yl)-OMe (E-2b): The procedure described 
above was applied using compound (E)-1 (178 mg, 0.500 mmol) and the 3-
benzo[b]thienylboronic acid (98.0 mg, 0.550 mmol) and heating for 3h. Column 
chromatography using a solvent gradient from pure petroleum ether to 30% diethyl ether 
in petroleum ether, gave compound (E)-2b (112 mg, 60%) as an oil. Recrystallization 
from diethyl ether/petroleum ether afforded colourless crystals, mp 171-172 ºC. 1H 
RMN (CDCl3): 1.48 (9H, s, CH3 Boc), 3.46 (3H, s, OCH3), 6.33 (1H, br s, NH), 7.19 
(1H, d, J = 7.8 Hz, ArH), 7.26-7.40 (8H, m, ArH), 7.81 (1H, d, J = 7.5 Hz, ArH) ppm 
13C RMN. (CDCl3): 28.09 (C(CH3)3), 52.09 (OCH3), 81.46 (OC(CH3)3), 122.49 (CH), 
123.21 (CH), 124.08 (CH), 124.30 (CH), 125.63 (CH), 127.57 (C), 128.45 (CH), 128.89 
(CH), 129.20 (CH), 131.94 (C), 134.59 (C), 136.75 (C), 138.09 (C), 139.81 (C), 152.54 
(C=O), 166.34 (C=O) ppm. Anal. calcd. for C23H23NO4S (409.50): C 67.46; H 5.66; N 
3.42; S 7.83; found C 67.30; H 5.94; N 3.51; S 7.64.  
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4.3.4. Boc-(Z)-∆Phe(β-benzo[b]thien-3-yl)-OMe (Z-2b): The procedure described 
above was applied using compound (Z)-1 (107 mg, 0.300 mmol) and the 3-
benzo[b]thienylboronic acid (59.0 g, 0.330 mmol) and heating for 3h. Column 
chromatography using a solvent gradient from pure petroleum ether to 30% diethyl ether 
in petroleum ether, gave compound (Z)-2b (62.0 mg, 50%) as an oil. Recrystallization 
from diethyl ether/petroleum ether afforded colourless crystals, mp 139-140 ºC. 1H 
RMN (CDCl3): 1.40 (9H, s, CH3 Boc),  3.61 (3H, s, OCH3),  5.92 (1H, br s, NH), 7.16-
7.20 (2H, m, ArH), 7.27-7.57 (6H, m, ArH), 7.58 (1H, d, J = 8.1 Hz, ArH), 7.90 (1H, d, 
J = 8.1 Hz, ArH) ppm. 13C RMN (CDCl3): 28.07 (C(CH3)3), 52.13 (OCH3), 81.38 
(OC(CH3)3), 122.79 (CH), 123.25 (C), 124.67 (CH), 124.82 (CH), 127.22 (C), 128.05 
(CH), 128.17 (CH), 128.41 (CH), 128.70 (CH), 134.16 (C), 136.84 (C), 139.39 (C), 
140.12 (C), 152.73 (C=O), 166.18 (C=O) ppm. Anal. calcd. for C23H23NO4S (409.50): C 
67.46; H 5.66; N 3.42; S 7.83; found C 67.53; H 5.79; N 3.50; S 7.72. The procedure 
described above substituting PdCl2(PPh3)2 for Pd(PPh3)4 was used giving compound (Z)-
2b (81.0 mg, 66%). 
 
4.3.5. Boc-(E)-∆Phe(β-2,3-dimethylbenzo[b]thien-7-yl)-OMe (E-2c): The procedure 
described above was applied using compound (E)-1 (178 mg, 0.500 mmol) and the 2,3-
dimethyl-7-benzo[b]thienylboronic acid (113 mg, 0.550 mmol) and heating for 4h 30m. 
Column chromatography using a solvent gradient from pure petroleum ether to 30% 
diethyl ether in petroleum ether, gave compound (E)-2c (209 mg, 96%) as an oil. 
Recrystallization from petroleum ether afforded colourless crystals, mp 152-154 ºC. 1H 
NMR (CDCl3): 1.47 (9H, s, CH3 Boc), 2.26 (3H, s, ArCH3), 2.36 (3H, s, ArCH3), 3.41 
(3H, s, OCH3), 6.24 (1H, br s, NH), 7.15 (1H, br d, J = 6.9 Hz, ArH), 7.31-7.36 (6H, m, 
ArH), 7.53 (1H, dd, J = 8.1 and 0.9 Hz, ArH) ppm. 13C NMR (CDCl3): 11.41 (CH3), 
13.63 (CH3), 28.13 (C(CH3)3), 51.99 (OCH3), 81.27 (OC(CH3)3), 120.89 (CH), 123.71 
(CH), 124.47 (CH), 126.70 (C), 127.06 (C), 128.06 (C), 128.45 (CH), 128.76 (CH), 
129.67 (CH), 133.50 (C), 134.48 (C), 136.60 (C), 138.07 (C), 141.48 (C), 152.70 (C=O), 
166.03 (C=O) ppm. Anal. calcd. for C25H27NO4S (437.55): C 68.62; H 6.22; N 3.20; S 
7.33; found C 68.64; H 6.44; N 3.29; S 7.02. 
 
4.3.6. Boc-Z-∆Phe(β-2,3-dimethylbenzo[b]thien-7-yl)-OMe (Z-2c): The procedure 
described above was applied using compound (Z)-1 (178 mg, 0.500 mmol) and the 2,3-
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dimethyl-7-benzo[b]thienylboronic acid (113 mg, 0.550 mmol) and heating for 4h 30m. 
Column chromatography using a solvent gradient from pure petroleum ether to 30% 
diethyl ether in petroleum ether, gave compound (E)-2c (162 mg, 74%) as an oil. 
Recrystallization from petroleum ether afforded colourless crystals, mp 140-142 ºC. 1H 
NMR (CDCl3): 1.42 (9H, s, CH3 Boc), 2.31 (3H, s, ArCH3), 2.42 (3H, s, ArCH3), 3.60 
(3H, s, OCH3), 5.89 (1H, br s, NH), 7.08-7.21 (3H, m, ArH), 7.23-7.30 (3H, m, ArH), 
7.38 (1H, t, J = 8.1 Hz, ArH), 7.59 (1H, d, J = 8.1 Hz, ArH) ppm. 13C NMR (CDCl3): 
11.46 (CH3), 13.67 (CH3), 28.08 (C(CH3)3), 52.19 (OCH3), 81.14 (OC(CH3)3), 121.26 
(CH), 124.38 (CH), 125.33 (CH), 126.99 (C), 127.93 (CH), 128.08 (CH), 128.78 (CH), 
129.69 (C), 132.00 (C), 134.87 (C), 137.87 (C), 138.59 (C), 141.78 (C), 152.67 (C=O), 
166.30 (C=O) ppm. Anal. calcd. for C25H27NO4S (437.55): C 68.62; H 6.22; N 3.20; S 
7.33; found C 68.54; H 6.35; N 3.24; S 7.05. The procedure described above substituting 
PdCl2(PPh3)2 for Pd(PPh3)4 was used  giving compound (Z)-2c (160 mg, 73%). 
 
4.4. Synthesis of the model dipeptide Boc-E-∆Phe-(β-benzo[b]thien-2yl)-Ala-OMe 
4.4.1. Synthesis of Boc-E-∆Phe-(β-benzo[b]thien-2yl)-OH (E-3): To a solution of 
Boc-E-∆Phe(β-benzo[b]thien-2-yl)-OMe (0.34 mmol, 137 mg) in dioxane (3 mL), 1 
equiv. of NaOH 1 M was added. The solution was left stirring for 18 h at rt (the reaction 
was followed by tlc until no starting material was detected). The reaction mixture was 
acidified to pH 2-3 with KHSO4 1 M and the solid formed filtered. Cristallization from 
ethyl acetate / n-hexane afforded compound (E)-3 (117 mg, 87%) as a light yellow solid, 
mp 189-191°C (from ethyl acetate / n-hexane). 1H RMN (CDCl3): 1.43 (9H, s, CH3 
Boc), 6.18 (1H, s, NH), 7.29-7.40 (8H, m, ArH), 7.70-7.73 (2H, m, ArH) ppm. 13C NMR 
(CDCl3): 28.08 (C(CH3)3), 82.01 (OC(CH3)3), 114.48 (C), 122.09 (CH), 123.87 (CH), 
124.38 (CH), 124.72 (CH), 125,23 (CH), 126.32 (C), 128.95 (CH), 129.02 (CH), 129.58 
(CH), 137,46 (C), 139.36 (C), 141.05 (C), 141.34 (C), 151.32 (C=O), 152.56 (C=O) 
ppm.  
 
4.4.2. Synthesis of Boc-E-∆Phe-(β-benzo[b]thien-2yl)-Ala-OMe (4): To a solution of 
Boc-E-∆Phe(β-benzo[b]thien-2-yl)-OH (0.20 mmol, 79,0 mg) in acetonitrile (5 mL), 
HOBt (0.22 mmol, 34 mg) and DCC (0.22 mmol, 44 mg) were added with vigorous 
stirring at 0oC. After 15 min, HCl,H-Ala-OMe (0,2 mmol, 28 mg) and NEt3 (0,2 mmol, 
0.03 mL) were added. The reaction was left stirring for 18 h at rt. The urea was removed 
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by filtration and the solvent removed at reduced pressure. The oily residue was dissolved 
in ethyl acetate (15 mL) and the solution washed with KHSO4 1 M (3 x 5 mL), NaHCO3 
1M (3 x 5 mL) and brine (3 x 5 mL). The organic layer was dried with MgSO4 and 
solvent removed at reduced pressure giving an oil which was submitted to column 
chromatography with diethyl ether / petroleum ether (2:1). Compound 4 was isolated as 
a white solid (74 mg, 80 %), mp 168-169°C (from diethyl ether / n-hexane). 1H RMN 
(CDCl3): 1.10 (3H, d, J = 7.2 Hz, βCH3 Ala), 1.44 (9H, s, CH3 Boc), 3.43 (3H, s, OMe), 
4.54-4.63 (1H, m, αCH Ala), 6.06 (1H, s, NH), 6.42 (1H, d, J = 7.5 Hz, NH), 7.27-7.41 
(8H, m, ArH), 7.73-7.78 (2H, m, ArH) ppm. 13C NMR (CDCl3): 17.82 (CH3), 28.13 
(C(CH3)3), 48.33 (CH), 52.17 (OMe), 81.52 (OC(CH3)3), 122.07 (CH), 123.57 (C), 
123.67 (CH), 124.45 (CH), 124.56 (CH), 125,18 (CH), 128.73 (CH), 128.96 (CH), 
129.54 (CH), 131.11 (C), 137,50 (C), 139.44 (C), 140.82 (C), 141.44 (C), 152.16 (C=O), 
164.29 (C=O), 172.60 (C=O) ppm. Anal. calcd. for C26H28N2O5S (480.58): C 64.98; H 
5.87; N 5.83; S 6.67; found C 64.94; H 5.95; N 5.82; S 6.66. 
 
 
4.5. In vitro antimicrobial activity 
 
Suspensions of the microorganism were prepared to contain approximately 108 cfu/mL 
and the plates were inoculated. A stock solution of the synthesized compound (1000 
µg/mL) in DMSO was prepared and graded dilutions of the tested compounds were 
incorporated in a cavity (depth 3mm, diameter 4mm) made in the center of the Petri dish 
(nutrient agar for antibacterial activity and sabouraud dextrose agar medium for 
antifungal activity). The plates were incubated at 37 oC (for bacteria) and at 30 oC (for 
fungi) for 24h in duplicate. 
 Positive control using only inoculation and negative control using only DMSO in the 
cavity were carried out.  
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